Marrone Bio Innovations (MBI) announces the availability of the biological fungicide, Amplitude for the 2018 growing season. This product uses the same active ingredient in the recently announced EPA approval of Stargus.

Amplitude is based on a new strain of Bacillus amyloliquefaciens discovered by MBI, with strong performance against white molds and soil diseases such as Phytophthora and Rhizoctonia and Fusarium as shown in field trials in the U.S., Canada and Europe.

Growers have a new choice of active ingredients that perform well on the group of fungi that cause white molds in row crops like soybeans, canola, pulses, dry beans, bulb vegetables and sunflower.

Amplitude is also complementary and additive to the broad spectrum of diseases covered by MBI’s first biofungicide, Regalia Rx, to help control white molds and soil diseases in row crops.

MBI is also testing this Bacillus-based product for seed treatment applications with key strategic partners.

“We are pleased to provide row crop growers with another tool to control white molds and soil diseases on a broad range of large acre crops and tuber and root crops, which have developed a resistance to conventional products," said Andre Trepanier, MBI’s director of marketing.

"The high level of performance of Amplitude means it can be used alone, or in conjunction with a conventional fungicide to enhance control, build a solid resistance management program and get better ROI overall.”